Active — Not RecruitingNot Applicable

Comparative (Short vs. Standard) Length Implants in Early Stability Patterns.

Yemen10 participantsStarted 2025-08-01

Plain-language summary

Early Stability of Short vs. Standard Dental Implants in the Posterior Mandible This study compares how well short dental implants (7mm) work compared to standard-length implants (11mm) when placed in the back part of the lower jaw. Both types of implants have special shallow threads designed to reduce stress on the bone. The main goal is to see how stable they are during the first 4 weeks after placement-a critical time for healing. * Short implants may be a good option for patients with limited jawbone height, avoiding the need for bone grafting. * Understanding their early stability helps dentists decide when it's safe to place teeth on them. * This study uses advanced tools like 3D scans (CBCT) and implant stability measurements (ISQ) to track healing. What will happen in the study? 1. Screening: A dental exam and 3D scan to check bone quality. 2. Implant Placement: * Short (7mm) or standard (11mm) implant, depending on your bone height. * Minimally invasive surgery with local anesthesia. 3. Follow-ups: Painless stability checks at end of 1, 2, 3, and 4 weeks using a small device (RFA). Who can participate? Adults (18-60 years) missing posterior teeth in the lower jaw, with: * Enough bone width (≥6.5mm). * No uncontrolled health conditions (e.g., severe diabetes). * Non-smokers or light smokers (\<10 cigarettes/day). * Benefits: Free implant placement and monitoring; contributes to better dental care. * Risks: Typical surgery risks (swelling, infection); rare nerve injury (\<5% chance). How long is the study? * Active participation: 4 weeks (with optional long-term follow-up). * Total study duration: \~12 months (including data analysis). Mohammad Abdulwahab Al-Jonaid University of Science and Technology, Sana'a. * Supervisor: Dr. Ali Al-Hudaied, Oral and Maxillofacial Surgery Specialist.

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1\. Adults ≥18 years with partial posterior mandibular edentulism. 2. Bone height ≥7 mm and width \>6 mm (CBCT-confirmed). 3. D2/D3 bone density (HU: 350-1250). 4. Healed posterior mandibular sites (3-6 months post-extraction). 5. Good oral hygiene (plaque index ≤1). 6. Willingness to adhere to study protocols. Exclusion Criteria: * 1\. Uncontrolled systemic diseases (e.g., diabetes with HbA1c \>7%, liver disease) or medications affecting bone healing (e.g., corticosteroids, bisphosphonates). 2\. History of head/neck radiotherapy (with in past year). 3. Heavy smoking (\>10 cigarettes/day). 4. Absolute contraindications for oral surgery (e.g., recent MI/CVA \< 6months, bleeding disorders). 5\. Active periodontal disease, parafunctional habits as bruxism, or prior bone grafting at the site.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Implant Stability Quotient (ISQ) at Baseline (T0)

Timeframe: Measurement at implant placement(Day 0)

Insertion Torque value- ITV.

Timeframe: Measurement at during implant placement (intraoperative)

Magnitude of Stability Dip

Timeframe: from implant placement (Day 0) through week4

Time of Onset of Secondary Stability

Timeframe: from Day0 , through week 4.

Trial details

NCT IDNCT07162389

SponsorUniversity of Science and Technology, Yemen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-01

View on ClinicalTrials.gov More Alveolar Bone Atrophy trials